Diabetes Intelligence Hub — Pakistan
Pakistan has one of the fastest-growing diabetes burdens in South Asia. This hub maps the medicine landscape — key molecules, competing brands, price positioning versus official DRAP ceilings, and the gaps where a new entrant can make a difference.
Diabetes in Pakistan
Data as of 2026-07-30. Prices are observed retail / official ceilings — not sales volumes. All figures are demand proxies, not real sales. See the full market intelligence dashboard for opportunity scoring across categories.
Key Molecules
Brand & Company Map
Top companies by diabetes brand count in the catalog.
Price Landscape vs DRAP Ceilings
Retail price range per molecule (DVAGO observed + DRAP official ceiling).
Partner Slots — Scarcity Is the Product
Anchor Partner
- Top placement on every hub page
- Verified education content — your logo on every page
- Quarterly category report included
- First-mover reference customer pricing
Verified Education Partner
- Verified product pages within the hub
- Named placement in partner directory
- Link to your product pages from molecule panels
Awareness Content
Understanding Diabetes in Pakistan
Pakistan has an estimated 33 million people living with diabetes — one of the highest prevalence rates in South Asia. Type 2 diabetes accounts for the vast majority of cases, driven by rapid urbanisation, dietary changes, and sedentary lifestyles.
Early diagnosis and consistent medication adherence are the two most impactful levers for reducing complications. The molecules tracked in this hub represent the standard treatment pathway from first-line (metformin) through second-line (SGLT2 inhibitors, GLP-1 receptor agonists) to insulin therapy.
Price Sensitivity & Access
The majority of Pakistani diabetes patients pay out-of-pocket. DRAP official ceilings set the legal maximum, but actual retail prices vary significantly across sources — DVAGO, Servaid, and DRAP-official pricing can differ by 2–10x for the same molecule.
This price spread creates both opportunity and risk: patients who cannot afford branded products may default to substandard alternatives, while companies with competitive pricing can capture significant market share.